Osteoporosis International

, Volume 19, Issue 7, pp 991–999 | Cite as

Secondary contributors to bone loss in osteoporosis related hip fractures

  • B. J. Edwards
  • C. B. Langman
  • A. D. Bunta
  • M. Vicuna
  • M. Favus
Original Article

Abstract

Summary

Osteoporosis treatment of patients with hip fractures is necessary to prevent subsequent fractures. Secondary causes for bone loss are present in more than 80% of patients with hip fractures, and therefore, assessment of Vitamin D status, disorders in calcium absorption and excretion, monoclonal gammopathies, and renal function should be performed. Identifying and managing these disorders will improve detection and enhance treatment aimed at reducing the risk of recurrent fractures in older adults.

Introduction

The purpose of this study was to determine the prevalence of disorders affecting bone and mineral metabolism in individuals with osteoporotic hip fractures.

Methods

Community dwelling individuals with hip fractures (HFx) 50 years of age and older. Assessment for vitamin D, renal and parathyroid status, calcium absorption, and plasma cell disorders.

Results

Of 157 HFx, mean age 70 ± 10 years, HFx had higher creatinine (p = 0.002, 95% C.I. −0.09, 0.05); lower 25 OH vitamin D (p = 0.019, 95% C.I. 6.5, 2.7), albumin (p = 0.007, 95% C.I. 0.36, 0.009), and 24-h urine calcium (p = 0.024, 95% CI 51, 21) as compared to controls. More than 80% of HFx had at least one previously undiagnosed condition, with vitamin D insufficiency (61%), chronic kidney disease (16%) (CKD), monoclonal gammopathy (6%), and low calcium absorption (5%) being the most common. One case each of multiple myeloma and solitary plasmocytoma were identified.

Conclusions

Osteoporosis treatment of HFx is necessary to prevent subsequent fractures. Secondary causes for bone loss are remarkably common in HFx; therefore, assessment of vitamin D status, disorders in calcium absorption and excretion, protein electrophoresis, and renal function should be performed. Identifying and correcting these disorders will improve detection and enhance treatment aimed at reducing the risk of recurrent fractures in older adults.

Keywords

Chronic kidney disease Fractures Myeloma Osteoporosis Vitamin D 

Notes

Conflicts of interest

None.

References

  1. 1.
    US Department of Health and Human Services, Bone Health and Osteoporosis: A report of the Surgeon General. Rockville MD: U.S. Department of Health and Human Services, Office of the Surgeon General; 2004Google Scholar
  2. 2.
    Colon-Emeric CS, Kuchibhtatla M, Pieper C et al (2003) The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteop Int 14:879–883CrossRefGoogle Scholar
  3. 3.
    Colon-Emeric CS, Sloane R, Hawkes WG (2000) The risk of subsequent fractures in community-dwelling men and male veterans with hip fracture. Am J Med 109:324–326PubMedCrossRefGoogle Scholar
  4. 4.
    National Osteoporosis Foundation (1998) Osteoporosis review of the evidence for prevention, diagnosis and treatment, and cost effectiveness Analysis. Osteoporos Int Suppl4:S1–S85Google Scholar
  5. 5.
    Lyles KW, Colon-Emeric CS, Magaziner J et al (2007) Efficacy and safety of Zoledronic acid 5 mg in preventing fractures in men and women with prevalent hip fractures: the horizon recurrent hip fractures trial. New Engl J Med (in press)Google Scholar
  6. 6.
    Edwards BJ, Bunta AD, Madison LD et al (2005) An osteoporosis and fracture intervention program increases the diagnosis and treatment for osteoporosis for patients with minimal trauma fractures. Jt Comm J Qual Patient Saf 5:267–274Google Scholar
  7. 7.
    Kaufman JD, Bolander ME, Bunta AD, Edwards BJ, Fitzpatrick LA, Simonelli C (2003) Barriers and solutions to osteoporosis care in patients with hip fracture. J Bone Joint Surg Am 85-A(9):1837–1843PubMedGoogle Scholar
  8. 8.
    Harrington JT, Deal CL (2006) Suceses and failures in improving osteoporosis care after fragility fractures: results of a multiple-site clinical improvement project. Arthritis Rheum 55:724–728PubMedCrossRefGoogle Scholar
  9. 9.
    American Orthopaedic Association (2005) Leadership in orthopaedics: taking a stand to own the bone. J Bone Joint Surg Am 87A:1388–1391Google Scholar
  10. 10.
    Kleerekoper M (2001) Evaluation of the patient with osteoporosis or at risk for osteoporosis. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis, vol 2. San Diego: Academic Press, pp 403–408CrossRefGoogle Scholar
  11. 11.
    Favus M (2005) Editorial: postmenopausal osteoporosis and the detection of so called secondary causes of low bone mass. J Clin Endocr Metab 90:3800–3801PubMedCrossRefGoogle Scholar
  12. 12.
    Tannenbaum C, Clark J, Schwartzman K et al (2002) Yield of laboratory testing to identify secondary contributor to osteoporosis in otherwise healthy women. J Clin Endocr Metab 87:4431–4437PubMedCrossRefGoogle Scholar
  13. 13.
    Holick M, Siris E, Binkley N et al (2005) Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocr Metab 90:3215–3224PubMedCrossRefGoogle Scholar
  14. 14.
    LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J (1999) Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA 281:1505–1511PubMedCrossRefGoogle Scholar
  15. 15.
    Simonelli CS, Weiss TW, Morancey J, Swanson L, Chen Y (2005) Prevalence of vitamin D inadequacy in a minimal trauma fracture population. Curr Med Res and Opinion 21:1069–1074CrossRefGoogle Scholar
  16. 16.
    Borson S, Scanlan JM, Chen P, Ganguli M (2003) The Mini-cog as a screen for dementia: validation in a population based sample. J Am Ger Soc 51:1451–1454CrossRefGoogle Scholar
  17. 17.
    Charlson ME, Pompei M, Ales KL (1987) A new method of classifying prognostic co-morbidity in longitudinal studies. J Chron Dis 40:373–383PubMedCrossRefGoogle Scholar
  18. 18.
    Hall N, Ramachandran R, Narayan S, Jani AB, Srinivasan R (2004) An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 4:94PubMedCrossRefGoogle Scholar
  19. 19.
    Extermann M (2000) Measuring comorbidity in older cancer patients. Eur J Cancer 36:453–471PubMedCrossRefGoogle Scholar
  20. 20.
    Gunter EW, Lewis BL, Koncikowski SM (1996) Laboratory methods used for the third National Health and Nutrition Examination Survey (NHANES III),1988–1994. Hyattsville, MD: Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/about/major/nhanes/NHANESIII_. Accessed 7/10/2006.
  21. 21.
    Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Int Med 139:137–147PubMedGoogle Scholar
  22. 22.
    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Int Med 134:161–170Google Scholar
  23. 23.
    Heaney RP, Recker R, Ryan RA (1999) Urinary calcium in perimenopausal women: normative values. Osteoporos Int 9:13–18PubMedCrossRefGoogle Scholar
  24. 24.
    Coe FL, Favus MJ, Crockett T et al (1982) Effects of low calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 72:25–32PubMedCrossRefGoogle Scholar
  25. 25.
    Lerolle N, Lantz B, Paillard F et al (2002) Risk factors for nephrolithiasis in patients with familial idiopathic hypercalciuria. Am J Med 113:99–103PubMedCrossRefGoogle Scholar
  26. 26.
    Lips P, Duong T, Oleksik A et al (2001) A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 86:1212–1221PubMedCrossRefGoogle Scholar
  27. 27.
    International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121:749–757CrossRefGoogle Scholar
  28. 28.
    Malabanan A, Veronikis IE, Holick MF (1998) Redefining vitamin D insufficiency. Lancet 351:805–806PubMedCrossRefGoogle Scholar
  29. 29.
    Heaney RP, Barger-Lux MJ, Dowell MS, Chen TC, Holick MF (1997) Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab 82:4111–4116PubMedCrossRefGoogle Scholar
  30. 30.
    Sahota O, Mundey MK, San P, Godber IM, Lawson N, Hosking DJ (2004) The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 35:312–319PubMedCrossRefGoogle Scholar
  31. 31.
    Heaney RP, Dowell MS, Hale CA, Bendich A (2003) Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22:142–146PubMedGoogle Scholar
  32. 32.
    Bischoff HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW (2004) Higher 25 Hydroxyvitamin D concentrations are associated with better lower extremity function in both active and inactive persons aged > 60 y. Am J Clin Nutr 80:752–758Google Scholar
  33. 33.
    Schott GD, Wills MR (1976) Muscle weakness in osteomalacia. Lancet 1:626–629PubMedCrossRefGoogle Scholar
  34. 34.
    Gloth FM, Lindsay JM, Zelesnick LB, Greenough WB (1991) Can vitamin D deficiency produce an unusual pain sydrome? Arch Intern Med 151:1662–1664PubMedCrossRefGoogle Scholar
  35. 35.
    Pfeifer M, Begerow B, Minne HW, Schollthauer T, Popeschill M, Scholtz M, Lazarescu AD (2001) Vitamin D status, trunk muscle strength, body sway, fall, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes 109:87–92PubMedCrossRefGoogle Scholar
  36. 36.
    Bischoff HA, Stahelin HB, Dick W (2003) Effects of Vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone and Mineral Res 18:343–351CrossRefGoogle Scholar
  37. 37.
    Bischoff-Ferrari HA, Conzelmann M, Stähelin HB et al (2006) Is fall prevention by vitamin D mediated by a change in postural or dynamic balance? Osteoporos Int 17:656–663PubMedCrossRefGoogle Scholar
  38. 38.
    Bischoff HA, Stahelin HB, Dick W. Effects of Vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003;18:343–351PubMedCrossRefGoogle Scholar
  39. 39.
    Chapuy MC, Arlot M, Delmas PD, Meunier PJ (1994) Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 308:1081–1082PubMedGoogle Scholar
  40. 40.
    Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41:1–12PubMedCrossRefGoogle Scholar
  41. 41.
    Klawansky S, Komaroff E, Cavanaugh PF Jr et al (2003) Relationship between age, renal function and bone mineral density in the US population. Osteoporos Int 14:570–576PubMedCrossRefGoogle Scholar
  42. 42.
    Levey AS, Perrone RD, Madias NE (1988) Serum creatinine and renal function. Annu Rev Med 39:465–490PubMedCrossRefGoogle Scholar
  43. 43.
    Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMedCrossRefGoogle Scholar
  44. 44.
    Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ (1984) Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 74:2136–2143PubMedCrossRefGoogle Scholar
  45. 45.
    Rix M, Andreassen H, Eskildsen P, Langhdal B, Oldgard K (1999) Bone mineral density and biochemical markers of bone turnover in patients with predyalisis chronic renal failure. Kidney Int 56:1084–1093PubMedCrossRefGoogle Scholar
  46. 46.
    Yendt ER, Cohanim M, Yarszylo S et al (1991) Bone mass is related to creatinine clearance in normal postmenopausal women. J Bone Miner Res 6:1043–1050PubMedCrossRefGoogle Scholar
  47. 47.
    Yendt ER, Cohanim M, Yarszylo S et al (1993) Reduced creatinine clearance in primary osteoporosis in women. J Bone Miner Res 8:1045–1052PubMedGoogle Scholar
  48. 48.
    Ensrud KE, Lui LL, Taylor BC et al (2007) Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 167:133–139PubMedCrossRefGoogle Scholar
  49. 49.
    Malluche HH, Ritz E, Lange HP et al (1976) Bone histology in incipient and advanced renal failure. Kidney Int 9:355–362PubMedCrossRefGoogle Scholar
  50. 50.
    Miller PD, Roux C, Boonen S, Barton IP, Dunlap LE, Burgio DE (2005) Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the cockcroft and gault method: a pooled analysis of nine clinical trials. J Bone Miner Res 20:2105–2115PubMedCrossRefGoogle Scholar
  51. 51.
    Jamal SA, Bauer DC, Ensrud KE et al (2007) Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res 22:503–508PubMedCrossRefGoogle Scholar
  52. 52.
    Miller PD, Schwartz EN, Chen P, Misurski DA, Krege KH (2007) Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int 18:59–68PubMedCrossRefGoogle Scholar
  53. 53.
    Sprague S (2007) Renal function and risk of hip and vertebral fractures in older women is it always osteoporosis? Arch Intern Med 167:115–116PubMedCrossRefGoogle Scholar
  54. 54.
    Schwartz AV, Hillier TA, Sellmeyer DE et al (2002) Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care 25(10):1749–1754PubMedCrossRefGoogle Scholar
  55. 55.
    Coyne D (2007) Chronic kidney disease and secondary hyperparathyroidism. Annual Meeting: International Society of Clinical Densitometry. TampaGoogle Scholar
  56. 56.
    USRDS: Annual Data Report C (1999) Incidence and prevalence of ESRD. Am J Kidney Dis 34:540–550Google Scholar
  57. 57.
    Ritz E, Rychlik I, Locatelli F, Halimi S (1999) End-stage renal failure in type 2 diabetes, a medical catastrophe of worldwide dimensions. Am J Kidney Dis 34(795–808)Google Scholar
  58. 58.
    Mogensen CE (1984) Microaluminuria predicts clinical proteinuria early mortality in maturity-onset diabetes. N Engl J Med 310:356–360PubMedCrossRefGoogle Scholar
  59. 59.
    Cunningham J, Sprague SM, Cannata-Andia J et al (2004) Osteoporosis in chronic kidney disease. Am J Kidney Dis 43(3):566–571PubMedCrossRefGoogle Scholar
  60. 60.
    Moe S, Dru¨eke T, Cunningham T et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69(11):1945–1953PubMedCrossRefGoogle Scholar
  61. 61.
    Cummings SR, Nevitt MC, Browner WS et al (1995) Risk factors for hip fracture in white women. N Engl J Med 332(12):767–773PubMedCrossRefGoogle Scholar
  62. 62.
    Cummings SR, Cawthon PM, Ensrud KE et al (2006) BMD and risk of hip and nonvertebral fractures in older men: a prospective study and comparison with older women. J Bone Miner Res 21:1550–1556PubMedCrossRefGoogle Scholar
  63. 63.
    Magaziner J, Wehren L, Hawkes WG et al (2006) Women with hip fracture have a greater rate of decline in bone mineral density than expected: another significant consequence of a common geriatric problem. Osteoporos Int 17:971–977PubMedCrossRefGoogle Scholar
  64. 64.
    Nguyen ND, Pongchaiyakul C, Center JR, Eisman JA, Nguyen TV (2005) Identification of high-risk individuals for hip fracture: a 14-year prospective study. J Bone Miner Res 20(11):1921–1928PubMedCrossRefGoogle Scholar
  65. 65.
    Lyles KW, Colon-Emeric CS, Pieper C et al (2007) The Horizon clinical fracture after recent hip fracture trial (RFT) study cohort description (SA405). American Society of Bone and Mineral Research. Honolulu, HawaiiGoogle Scholar
  66. 66.
    Ireland P, Fordtran JS (1973) Effect of dietary calcium and age on jejunal calcium absorption in humans studied bylIntestinal Perfusion. J Clin Invest 52:2672–2681PubMedCrossRefGoogle Scholar
  67. 67.
    Ensrud KE, Duong T, Cauley JA et al (2000) Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Study of Osteoporotic Fractures Research Group. Ann Int Med 132(5):345–353PubMedGoogle Scholar
  68. 68.
    Food and Nutrition Board, Institute of Medicine (1997) Dietary reference intakes for calcium, magnesium, phosphorus, vitamin D, and fluoride. Washington, DCGoogle Scholar
  69. 69.
    Asplin JR, Donahue S, Kinder J, Coe FL (2006) Urine calcium excretion predicts bone loss in idiopathic hypercalciuria. Kidney Int 70(8):1463–1467PubMedCrossRefGoogle Scholar
  70. 70.
    Borghi L, Schianchi T, Meschi T et al (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346:77–84PubMedCrossRefGoogle Scholar
  71. 71.
    Misael da Silva AM, dos Reis LM, Pereira RC et al (2002) Bone involvement in idiopathic hypercalciuria. Clin Nephrol 57:183–191PubMedGoogle Scholar
  72. 72.
    Mariette X, Khalifa P, Ravaud P et al (1992) Bone densitometry in patients with multiple myeloma. Am J Med 93:595–598PubMedCrossRefGoogle Scholar
  73. 73.
    Abildgaard N, Brixen K, Kristensen JE, Vejlgaard T, Charles P, Nielsen JL (1996) Assessment of bone involvement in patients with multiple myeloma using bone densitometry. Eur J Haematol 57:370–376PubMedCrossRefGoogle Scholar
  74. 74.
    Melton III LJ, Rajkumar SV, Khosla S, Achenbach SJ, Ooberg AL, Kyle RA (2004) Fracture risk in monoclonal gammopathy of undetermined significance. J Bone Miner Res 19:25–30PubMedCrossRefGoogle Scholar
  75. 75.
    American Association of Clinical Endocrinologists (2002) American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients—2002 update. Endocr Pract 8(6):440–456Google Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2007

Authors and Affiliations

  • B. J. Edwards
    • 1
    • 3
  • C. B. Langman
    • 2
  • A. D. Bunta
    • 3
  • M. Vicuna
    • 1
  • M. Favus
    • 4
  1. 1.Bone Health and Osteoporosis Center, Department of Medicine, Feinberg School of MedicineNorthwestern UniversityChicagoUSA
  2. 2.Bone Health and Osteoporosis Center, Department of Pediatrics, Feinberg School of MedicineNorthwestern UniversityChicagoUSA
  3. 3.Bone Health and Osteoporosis Center, Department of Orthopaedic Surgery, Feinberg School of MedicineNorthwestern UniversityChicagoUSA
  4. 4.Department of MedicineUniversity of ChicagoChicagoUSA

Personalised recommendations